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This work aimed to study the cytotoxic effect of L-asparaginase isolated from local Withania somnifera 
plant on lymphocyte leukemia cells. To achieve this goal, L-asparaginase was purified from W. 
somnifera fruits by two purification steps, ion-exchange chromatography using DEAE-cellulose and gel 
filtration chromatography using Sephadex G-150, and the study utilized an in vitro evaluation for the 
cytotoxic effect of the partially purified L-asparaginase with concentrations ranging (12.5 to 100 μg/ml) 
in a two fold serial dilutions on some cell suspension culture including, acute lymphocyte leukemia and 
chronic lymphocyte leukemia culture at different concentrations (12.5 to 100 μg/ml) and different 
exposure time of treatment (24, 48 and 72 h). This two purification steps raised the specific activity from 
1.73 U/mg in crude extract to 2.29 U/mg after ion-exchange and 10.5 U/mg after gel filtration; the 
purification fold was 1.32 after ion-exchange and 6.06 after gel filtration, the enzyme recovery was 56% 
after two purification steps and the results, pointed that acute lymphocyte leukemia culture showed 
highest sensitivity toward the cytotoxic effect (62.3±0.9%) of the partial purified L-asparaginase (100 
μg/ml) than other culture after 48 h in a dose dependent manner, and highest cytotoxic inhibitory effect 
(73.2±1.6%) after 48 h of exposure on chronic lymphocyte leukemia culture, while healthy lymphocyte 
culture showed novel behavior. The lowest concentration of cell treatment gave the most significant (P< 
0.01) inhibitory effect. The conclusion is that there is enough evidence to support the claim that L-
asparaginase from W. somnifera may be considered chemotherapeutic agent against cancer, such as 
acute lymphoblastic leukemia and lymphosarcoma. 
 






Leukemia is a cancer originating in any of hematopoietic 
cell that tends to proliferate as single cells within bone 
marrow and often circulate in the blood stream. Lympho-
cytic leukemia’s are derived from B or T cell precursors. 
Four types of leukemia are classified, Chronic Lympho-
cytic Leukemia (CLL), chronic myelogenous leukemia 
(CML), acute lymphocytic leukemia (ALL) and acute myelo-
genous leukemia (AML). The development of a malignant 
cell clone is due to the dysregulation of the balance 
between cell proliferation and the programmed cell death 
apoptosis (Conter et al., 2005). L- asparaginase is an 
enzyme that destroys asparagines external to the cell.
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Normal cells are able to make all the asparagine they 
need internally whereas tumor cells become depleted 
rapidly and die. The enzyme converts asparagine in the 
blood into aspartic acid by a deamination reaction; the 
leukemia cells are thus deprived of their supply of aspa-
ragine and will die (Grossman et al., 2004). Leukaemic 
cells lacking the mammalian asparagine-synthetase 
enzyme depend on exogenous sources of asparagine for 
protein synthesis and survival. Theoretically, the deami-
nation of serum asparagines selectively kills leukaemic 
cells, leaving normal cells, which have the ability to 
synthesize asparagine intracellularly, unaffected (Broome, 
1968). L-Asparaginase is known as a chemotherapeutic 
agent against cancer, such as acute lymphoblastic leu-
kemia and lymphosarcoma, which is used mainly in the 
treatment of children (Borek and Jaskolski, 2001). 
The current study was aimed at the in vitro cytotoxic 
study of the partial purified L-asparaginase on different 
types of suspension cell lines at different concentrations 
and exposure times. 
 
 
MATERIALS AND METHODS 
 
Sample collection of plant 
 
The fresh leaves, unripe and ripe fruits of W. somnifera plant 
collected from the garden of plants in Baghdad University were 
included in this study. The plant parts were cleaned from the dust 
and other particles and stored in the freezer until use. 
 
 
Extraction of L-asparaginase from plant tissues 
 
After cleaning the plant tissues with distilled water, the plant tissues 
(leaves, unripe fruits and ripe fruits) were homogenized and 
approximately 3 g from each sample were ground with 2 m
3
 of 
potassium phosphate buffer 0.1 M (pH 8.6) in a pestle and mortar, 
left on magnetic stirrer for 10 min, the extract was filtered to rid the 
cell debris, centrifuged at 12000 rpm for 10 min and the 
supernatant was taken to determine the L-asparaginase activity and 




Extraction of L-asparaginase using liquid nitrogen 
 
The plant tissues (leaves, unripe fruits and ripe fruits) were 
homogenized in liquid nitrogen, as the same as aforementioned. 
 
 
Determination of L-asparaginase activity 
 
0.5 ml of enzyme crude extract, 0.5 ml of 50 mM asparagine and 1 
ml potassium phosphate buffer (0.02 M and pH 8.6) were mixed 
well, the mixture was incubated in water bath at 37°C for 15 min, 
after the incubation, 1 ml of 1.5 M trichloroacetic acid was added to 
the mixture to stop the reaction, then centrifuged at 12000 rpm for 
10 min and the supernatant was collected (Ren et al., 2010). After 
that, the supernatant was transported to clear test tubes to 
determine the concentration of ammonia liberated from the enzyme 
action by the method of direct nesslerization, the concentration of 
ammonia was estimated for each sample by mixing 4 ml of distilled 





reagent, the mixing was shaken well, incubated at 37°C for 15 min, 
and the absorbance was measured at wave length (450 nm). The 




Purification of L-asparaginase 
 
Preparation of ion exchange column (DEAE-cellulose) 
 
The DEAE-cellulose column was prepared according to the method 
suggested by Whitaker (1972), the resin was packaged gently in 
glass column, the dimensions of resin was 1 × 24 cm, and the 
equilibration was achieved by the same potassium phosphate 
buffer at flow rate approximately 30 ml/h to next day. 
 
 
Separation through ion exchange resin (DEAE-cellulose) 
 
10 ml from enzyme crude extract was loaded onto ion exchange 
column, the separated fractions was collected at flow rate of 30 
ml/h approximately (2 ml for each fraction), the wash was achieved 
by using potassium phosphate buffer, the same buffer used in 
equilibration, and the elution was achieved by the same buffer used 
in equilibrium with graduated concentrations of potassium chloride 
(0.1, 0.05, 0.02 and 0.01 M) respectively; the flow rate of elution 
was 30 ml/h too, the protein concentration of the fractions was 
measured at wave length 280 nm and enzymatic activity was 
estimated for fractions as in Ren et al. (2010) and the fractions 
which give higher activity was collected, lyophilized (freeze dried), 
and stored in the freezer until use. 
 
 
Gel filtration chromatography   
 
Preparation of sephadex G-150 column 
 
Preparation of gel was achieved as recommended by the supply 
company (Sigma, USA). 5 g from gel sephadex G-150 was 
suspended in 1 L Tris-HCl buffer (0.1 M) and pH 8.6, then the 
suspension was left in water bath at 90°C for 5 h to ensure the 
swelling of gel beads with gentle agitation from time to time, after 
that, the gel was transferred to graduated cylinder, left to stagnate 
for 20 min, then the supernatant was removed, the gel was 
resuspended in 600 ml of Tris-HCl buffer, then the gel was 
degassed by using vacuum, then, packaged gently in glass column 
with dimensions (1 × 28) cm. The column was equilibrated using 
same buffer used in gel suspension at flow rate of 20 ml/h 
approximately until the next day. 
 
 
Separation through sephadex G-150 column 
 
The lyophilized extract produced from ion exchange step was 
suspended in 5 ml Tris-HCl buffer, the suspension was added 
gently on the surface of gel, the elution was done by using the 
same buffer (Tris-HCl) at flow rate of 20 ml/h (2 ml for each 
fraction), the protein concentrations for fractions was measured at 
wave length of 280 nm, the enzyme activity was estimated 
according to method mentioned in Ren et al. (2010), then the 
fractions with higher enzyme activity was collected, lyophilized and 
stored in freeze for other steps. 
 
 
Preparation of L-asparginase dilutions 
 
Pure L-asparaginase stock solution was prepared by dissolving 5 m 






at -20°C until used. Serial dilutions were made starting from 
concentration 100, 50, 25 and 12.5 µg/ml. The dilutions were done 




Sample collection of blood 
 
5 ml of blood was collected by vein puncture from 10 (ALL and 
CLL) cases for each, and 5 healthy persons (control) who were 
admitted to the National Center of Hematology Diseases / Al 
Mustanisyria University. The patients were diagnosed by the 
consultant medical staff at the centre. 
 
 
Isolation of lymphocytes 
 
Preparation of solutions and media were done according to the 
methods described by Marlise (1997) and Bottran and Vetvicka 
(2001). The lymphocytes were isolated from the peripheral heap-
rinized whole blood as follows: 3 ml of blood was centrifuged at 
1000 rpm for 15 min, buffy coat was collected in a 10 ml centrifuge 
tubes and diluted with 5 ml RPMI 1640 (cell suspension),  5 ml of 
the diluted cell suspension was layered on 3 ml of ficoll-isopaque 
separation fluid, and the tubes were centrifuged at 2000 rpm for 30 
min in a cooled centrifuge at 4°C. After centrifugation, the mono-
nuclear cells were visible as cloudy band between the RPMI1640 
and lymphoprep layers. The band was collected in a 10 ml test tube 
and the cells were suspended in 5 ml RPMI 1640. The tube was 
centrifuged at 2000 rpm for 5 min, the supernatant was discarded 
and the cells were resuspended in 5 ml RPMI 1640 (repeated 
twice). The suspension was centrifuged at 1000 rpm for 10 min, 
and the supernatant was discarded. The precipitated cells were 
resuspended in 1 ml RPMI media Boyum (1968) and viable count 
were performed (Porakishvili et al., 2004), the numbers of 
lymphocytes were counted by improved neuber chamber and the 
cells concentration was adjusted to 1 × 10
6
 cell/ml. The isolated 
cells were grown in a flask containing 10 ml RPMI 1640 medium 
supplemented with bovine serum albumin (BSA) and incubated at 
37°C for 48 h in CO2 incubator (Boyum, 1968). 
 
 
3 (dimethylthiazol-2-yl) -2,5- (diphenyltetrazoliumbromide) MTT 
 
A 50 mg MTT dye was dissolved in 100 ml distilled water. The 
solution was filtered through 0.22 µm millipore filter to remove any 
blue formazan product and stored in a sterile, dark screw–capped 





It is also called a cell growth inhibition assay. The in vitro method 
was used to investigate the effect of pure L-asparaginase on two 
types of leukemia culture (ALL- acute lymphocyte leukemia; CLL- 
chronic lymphocyte leukemia) at different concentrations (100, 50, 
25 and 12.5 µg/ml) and exposure times (24, 48 and 72 h) (Masters, 
2000). Using a microtiteration plate (96 wells) and cell culture 
technique, 4 × 10
5 
cells/ml were exposed to serial dilutions of L-
asparaginase in the concentrations range mentioned earlier. At the 
end of the exposure times, 10 µl of MTT solution was added to all 
wells and incubated for 4 h at 37°C, during this period, formazon 
crystals were formed at the bottom of each well. The spent medium 
was pipetted out along with suspension of culture and 100 µl of acid 
isopropanol (100 µl of 0.04N HCL in anhydrous isopropanol) was 
added to all wells and mixed thoroughly to dissolve the dark blue 
crystals and incubated in shaker at room temperature for 30 min. 
The  plates  of  different  cell  culture  at  the  end of the assay were 




examined by ELISA reader at 540 nm transmitting wave length 
(Skehan et al., 1990; Mosmann, 1983). The inhibition was calculated 





     Correct sample 
% inhibition = 100 –            × 100 





Correct sample = Growth cell GC – negative control, correct solvent 
= solvent control (SC) – negative control, RPMI 1640 + PBS 
(negative control), RPMI + cell [cell growth control (GC)], RPMI 






The statistical analysis is a very important final step in the research 
to analyse and evaluate the obtained results. Medical statistics of 
this study was conducted via computer based statistical program 
which was: 1) SPSS for windows computer package (programmer 
11.5; 2) Microsoft excel 2003. 
The statistical analysis system (SAS, 2004) was applied for all 
results to show effect of different concentration and other factors in 
studied parameters. The least significant difference (LSD) test and 
Duncan test are the comparative between means in this study. It is 
a well used test for the medical statistics; P value <0.01 is considered 
a significant correlation. 
 
 
RESULTS AND DISCUSSION 
 
Cytotoxic effect growth inhibitory assays of the 
partial purified L-aspariginase 
 
L-asparaginase has been purified from W. somnifera 
fruits by two purification steps, ion-exchange chromate-
graphy using DEAE-cellulose and gel filtration chromate-
graphy using sephadex G-150; using these two steps, the 
specific activity was raised from 1.73 U/mg in crude 
extract to 2.29 U/mg after ion-exchange and 10.5 U/mg 
after gel filtration; the purification fold was 1.32 after ion-
exchange and 6.06 after gel filtration; the enzyme recovery 
was 56% after using the two purification steps. Three cell 
lines were studied (ALL, CLL, Healthy) at three times of 
exposure (24, 48 and 72 h), using a two fold dilutions to 
get concentration from 100 to 12.5 µg /ml of partial 
purified L-aspariginase. The cytotoxic effect on acute 
lymphocyte leukemia culture (Table 1) revealed that the 
high concentrations gave a significantly (P<0.01) high 
inhibition rate of cells while being low gradually with low 
concentrations. After 48 h of exposure, a high cytotoxic 
inhibitory effect (5%) of the extract was started at the 
concentration (100 µg/ml). The extracted partial purified 
L-aspariginase was very sensitive and liable through 
many environmental changes even with suitable protection 
which led to the best results at 48 h of exposure than 
after 72 h of cells treatments. This might explain the more 
significant inhibition rate at different concentration for 48 
h than 72 h of exposure.  
Table 1 shows the results of the significant effect at P < 
0.01 level after 48 h of exposure. The highest concentration 
 




Table 1. The cytotoxic effect of extract pure L-asparaginase on three types of suspension leukemia culture (at 24, 48 and 72 h) of 
exposure. 
 
Treatment  Concentration (µg/ml) 
Time (h) 
24 48 72 
ALL 
100 33.6 ± 0.6
a
 62.3 ± 0.9
a
 20.1 ± 0.2
a
 
50 30.7 ± 1.01
b
 58.6 ± 0.5
b
 20.6 ± 0.7
a
 
25 20.5 ± 0.3
c
 50.3 ± 0.7
c
 19.5 ± 0.3
a
 
12.5 19.8 ± 0.4
d
 40.1 ± 0.006
d
 15.1 ± 0.3
b
 
     
CLL 
100 55.3 ± 2.6
a
 73.2 ± 1.6
a
 26.3 ± 0.6
a
 
50 31.7 ± 0.6
b
 54.9 ± 0.9
b
 15.8 ± 3.1
b
 
25 25.2 ± 1.1
c
 51.1 ± 2.7
b
 -17.5 ± 1.1
c
 
12.5 6.8 ± 0.5
d
 48.4 ± 0.6
c
 -39.6 ± 0.5
d
 
     
Healthy  
100 2.6 ± 0.7
a
 2.9 ± 0.5
a
 2.9 ± 0.5
a
 
50 2.5 ± 0.3
a
 2.3 ± 0.2
a
 -10.1 ± 0.09
b
 
25 2.2 ± 0.04
a
 2.7 ± 0.3
a
 -13.3 ± 0.2
b
 
12.5 1.8 ± 0.6
a
 2.2 ± 0.4
a








(100 µg/ml) of L-aspariginase, showed the highest cyto-
toxic inhibitory effect (62.3 ± 0.9%); the inhibitory effect 
decreased (33.6 ± 0.6, 20.1 ± 0.2%) after 24 and 72 h of 
exposure respectively on acute lymphocyte leukemia 
culture and highest cytotoxic inhibitory effect (73.2 ± 
1.6%) after 48 h of exposure on chronic lymphocyte 
leukemia culture. The L-asparaginase was an antiproli-
ferative effect without a significant inhibitory effect (2.6 ± 
0.7, 2.5 ± 0.3, 2.2 ± 0.04 and 1.8 ± 0.6%) at concen-
trations (100, 50, 25 and 12.5 µg/ml) respectively; after 
24 h of exposure, healthy lymphocyte culture and the 
cytotoxic inhibitory effect decrease to reach -16.9 ± 0.3% 
after 72 h of exposure for 12.5 µg/ml concentration then 
reached (2.9 ± 0.5, 2.3 ± 0.2, 2.7 ± 0.3 and 2.2 ± 0.4%) 
respectively for all concentration in descending manner 
respectively for 48 h of exposure. Among the three types 
of cell suspension (ALL, CLL and Healthy) at all concen-
tration and different intervals of exposure (24, 48 and 72 
h), the extracted purified L-aspariginase had the best 
efficiency in inhibiting CLL culture within (100 µg/ml) 48 h 
which was about 73.2 ± 1.6%. 
Oza et al. (2009) showed the enzyme was purified and 
characterized from W. somnifera, a popular medicinal 
plant in South East Asia and Southern Europe and a 
traditionally used Indian medicinal plant (Oza et al., 
2009). L-asparaginase (E.C. 3.5.1.1) is used as a thera-
peutic agent in the treatment of acute childhood lympho-
blastic leukemia (Oza et al., 2011). L-aspara-ginases are 
known chemotherapeutic agents against cancer, such as 
acute lymphoblastic leukemia and lymphosarcoma. 
Several recent reviews are available concerning the use 
of L-asparaginase in cancer therapy (Muller and Boos, 
1998; Oza et al., 2011). Leukaemic cells lacking the 
mammalian asparagine-synthetase enzyme depend on 
exogenous sources of asparagine for protein synthesis 
and survival. Theoretically, the deami-nation of serum 
asparagines selectively kills leukaemic cells, leaving 
normal cells, which have the ability to synthesize 
asparagine intracellularly and unaffected (Broome, 1968). 
Asparaginase is an enzyme which produces its anti-
cancer effects by “breaking down” asparagine, a 
substance normally found in the body that is involved in 
biological processes essential for cells to maintain life. 
Healthy cells are able to create asparagine for 
themselves; however, cancer cells are not able to create 
asparagine. Therefore, the depletion of asparagine by 
asparaginase kills cancer cells, while healthy cells are not 






L-asparaginase purified from W. somnifera fruits may be 
considered as a chemotherapeutic agent against acute 
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